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receptors revisited
Abstract
Clustering of neurotransmitter receptors in the postsynaptic membrane is critical for efficient synaptic
transmission. During neuromuscular synaptogenesis, clustering of acetylcholine receptors (AChRs) is an
early sign of postsynaptic differentiation. Recent studies have revealed that the earliest AChR clusters
can form in the muscle independent of motorneurons. Neurally released agrin, acting through the
muscle-specific kinase MuSK and rapsyn, then causes further clustering and localization of clusters
underneath the nerve terminal. AChRs themselves are required for agrin-induced clustering of several
postsynaptic proteins, most notably rapsyn. Once formed, AChR clusters are stabilized by several
tyrosine kinases and by components of the dystrophin/utrophin glycoprotein complex, some of which
also direct postnatal synaptic maturation such as formation of postjunctional folds. This review
summarizes these recent results about AChR clustering, which indicate that early clustering can occur in
the absence of nerves, that AChRs play an active role in the clustering process and that partly different
mechanisms direct formation versus stabilization of AChR clusters.
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1  Abstract 
 
Clustering of neurotransmitter receptors in the postsynaptic membrane is critical for efficient 
synaptic transmission. During neuromuscular synaptogenesis, clustering of acetylcholine receptors 
(AChRs) is an early sign of postsynaptic differentiation. Recent studies have revealed that the 
earliest AChR clusters can form in the muscle independently of motorneurons. Neurally-released 
agrin, by acting through the muscle-specific kinase MuSK and rapsyn, then causes further 
clustering and localization of clusters underneath the nerve terminal. AChRs themselves are 
required for agrin-induced clustering of several postsynaptic proteins, most notably rapsyn. Once 
formed, AChR clusters are stabilized by several tyrosine kinases and by components of the 
dystrophin/utrophin glycoprotein complex, some of which also direct postnatal synaptic maturation 
such as formation of postjunctional folds.  This review summarizes these recent results about AChR 
clustering, which indicate that early clustering can occur in the absence of nerves, that AChRs play 
an active role in the clustering process, and that partly different mechanisms direct formation versus 
stabilization of AChR clusters.  
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Cellular communication in the nervous system is mediated by synapses, the points of contact 
between neurons and their target cells. Here, synaptic vesicles in the nerve terminal release 
neurotransmitter molecules which diffuse across the synaptic cleft and activate neurotransmitter 
receptors in the postsynaptic membrane. These receptors must be present at high density in clusters 
precisely opposite sites of neurotransmitter release in the nerve ending, to ensure rapid and precise 
synaptic transmission. During formation of synapses, thus, clustering of neurotransmitter receptors 
is a key aspect of postsynaptic differentiation and is under tight temporal and spatial regulation [1, 
2]. 
Many aspects of receptor clustering originate from studies on the vertebrate neuromuscular 
junction (NMJ). Here, the postsynaptic muscle membrane harbors an elaborate postsynaptic 
apparatus composed of many identified proteins, whose hallmark is the high density of 
acetylcholine receptors (AChRs), reaching up to 10,000 molecules per μm2 [1]  (Fig. 1). Several 
extended reviews about the NMJ have recently appeared [1-7], dealing with all aspects of NMJ 
formation, maturation and elimination. In this review, we focus largely on one key and classic 
aspect of synaptogenesis at the NMJ, the clustering and maintenance of postsynaptic AChRs in high 
density. Although this topic has been intensely investigated for several decades, we revisit AChR 
clustering and postsynaptic assembly here, because recent studies reveal fundamentally new ways 
in which these processes occur, thereby changing old concepts of NMJ formation. 
 
3 Formation of AChR clusters and the postsynaptic apparatus 
 
While AChRs at the adult NMJ are highly concentrated in the postsynaptic membrane, they are 
virtually absent from the extrasynaptic plasma membrane. This distribution of receptors is caused 
by three major signaling processes [1, 2]. First, upon contact of the growing motorneuron with the 
developing muscle, pre-existing diffusely distributed AChRs – which are present at a density of 
about 1000 receptors per μm2 – are redistributed to form clusters at sites of nerve-muscle contact, 
although initially some aneural AChR clustering  is also observed at a distance from the nerve [8-
10]. Second, underneath the nerve terminal, muscle nuclei, which will become specialized synaptic 
nuclei, start to transcribe genes encoding AChRs at elevated levels. Third, gene transcription of 
AChR subunits is arrested in extrasynaptic nuclei. Together, these three processes ensure that 
AChRs are maintained in high density in clusters in the postsynaptic membrane and not throughout 
the whole muscle sarcolemma. In this review, we largely focus on the first two of these processes, 
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which lead to redistribution of pre-existing AChRs and to enhanced new synthesis of AChRs at the 
synapse.  
 
3.1  Agrin is a central player for formation of the NMJ 
 Recent studies show that at the time of the earliest contacts between nerve and muscle (E14.5 in 
the mouse), AChRs can form aneural clusters that are located at a distance from the motorneuron 
[9]. These clusters can, in fact, be formed in the complete absence of motorneurons, revealing a 
muscle program of differentiation termed pre-patterning that leads to nerve-independent AChR 
clusters in the central endplate zone of the muscle [8, 10]. Interestingly, also myotubes cultured in 
vitro in the absence of motorneurons can form a limited number of spontaneous AChR clusters. The 
mechanism of formation of these clusters will be discussed later. However, as development 
proceeds, AChR clusters become concentrated in the close vicinity of the nerve and appear strictly 
nerve-associated by E18.5 and later in the mouse. Thus, the nerve is essential for refinement of 
AChR clusters and can induce aggregation of AChRs in the muscle, as shown by classic studies in 
which neurons are cocultured with myotubes in vitro [11]. 
A key factor for clustering of pre-existing AChRs is neural agrin, a multi-domain proteoglycan 
released by the nerve [11] (Fig. 2A). Agrin was originally isolated from the electric organ of 
Torpedo californica based on its ability to aggregate AChRs in myotubes in culture [11] and was 
shown in subsequent studies to be the main organizer of the NMJ.  
Due to differential splicing, agrin exists in several isoforms that differ in their ability to induce 
AChR clusters [12, 13] (Fig. 2A). Isoforms containing inserts at the B/z site are synthesized by 
motorneurons, collectively termed neural agrin, and are highly active in AChR clustering assays. In 
contrast, muscle and Schwann cells express forms that lack B/z inserts and are inactive in 
clustering. With respect to the N-terminus, agrin exists in two main forms (Fig. 2A). An isoform 
with a longer N-terminus contains a unique region termed NtA domain in chick [14]. In mouse, this 
agrin form is designated LN-agrin and in chick SS-NtA-agrin [15, 16]. It is expressed in both neural 
and nonneural tissue, appears to account for most of the agrin in motorneurons and muscle, and is 
efficiently secreted and incorporated into the basal lamina [14, 15]. SN-agrin in mouse (called TM-
agrin in chick), in contrast, contains a shorter N-terminus, was the first agrin to be cloned (from rat 
[17]), is mainly expressed in the brain [15, 16], and associates with the plasma membrane without 
being secreted. In fact, SN-agrin is a type II transmembrane protein with a cytoplasmic N-terminus, 
because its N-terminal region serves as a uncleaved signal-anchor domain [16]. When expressed in 
a cell-bound form in transfected cells, SN-agrin is also able to induce AChR clusters in myotube 
cultures [16]. 
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While the biological roles of SN-agrin in vivo have yet to be elucidated, two main approaches 
have demonstrated that LN-agrin containing the NtA domain and B/z inserts is required to induce 
AChR clustering and assembly of the postsynaptic apparatus at the NMJ. In the first approach, the 
agrin gene was inactivated by homologous recombination. The resulting agrin-deficient knock-out 
mice lack differentiated NMJs and clusters of AChRs and other postsynaptic marker proteins are no 
longer observed in association with the nerve at birth, by which time the animals die due to failure 
to breathe [18]. Mice in which agrin isoforms containing B/z inserts were selectively abolished [19], 
and mice that selectively lack LN agrin isoforms [15], show the same deleterious phenotype as the 
full agrin knockout (that lacks all agrin proteins), confirming the importance of these specific 
isoforms in NMJ formation.  
In the second approach, agrin cDNA was microinjected ectopically into myofibers in vivo. In 
the case of neural but not muscle agrin isoforms, the injection causes the formation of ectopic 
postsynaptic specializations that contain clustered AChRs in association with many other 
postsynaptic proteins, deep membrane folds, and adult-type AChRs with ε subunits [20-24]. This 
gain-of-function approach demonstrates that neural agrin is sufficient to induce postsynaptic 
specialization in muscle. In fact, apparently through an indirect mechanism (see below), ectopically 
injected agrin also causes local gene expression of postsynaptic proteins such as AChRs, MuSK and 
ErbB receptor tyrosine kinases, whose mRNAs are likewise normally accumulated at NMJs [25]. 
Thus, agrin not only directs clustering of pre-existing postsynaptic proteins, but, through interaction 
with other signaling pathways, also leads to local gene expression of at least some of these 
postsynaptic components [25]. 
In addition, presynaptic differentiation may also be induced by agrin, as illustrated in agrin-
deficient mice, where motorneurons grow extensively over muscle fibers of the diaphragm, without 
being restricted to the central endplate zone [18]. In line with this are tissue culture experiments that 
show that agrin expressed in heterologous cells induces growth inhibition and differentiation of 
neurites from co-cultured ciliary ganglion neurons [26].  
 
3.2  The receptor tyrosine kinase MuSK is a component of the agrin receptor 
Many steps in clustering of AChRs induced by agrin remain unclear, although agrin signaling 
and postsynaptic assembly have been the topic of intense research for many years. Clearly, 
however, a receptor complex in the muscle membrane is activated by agrin released from the nerve. 
This receptor initiates a signaling cascade that culminates in clustering and anchoring of AChRs 
with the help of intracellular and AChR-associated signaling and anchoring proteins [2, 6, 11]. A 
key component of the agrin receptor is the muscle-specific kinase MuSK, a receptor tyrosine kinase 
(RTK) originally identified in Torpedo electric organ [27] and highly expressed in myotubes and 
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muscle fibers [28] (Fig. 2B). Gene targeting has been applied to examine the role of MuSK in NMJ 
development. MuSK-deficient mice lack differentiated NMJs, clusters of AChRs and other 
postsynaptic marker proteins, and thus show similarities in their phenotype to animals lacking agrin 
[29]. Furthermore, whereas wild-type myotubes respond to agrin treatment by a rapid tyrosine 
phosphorylation of MuSK followed by AChR clustering, cultured MuSK -/- myotubes fail to cluster 
the AChR in response to agrin [30].  
In a gain-of-function approach, a constitutively active recombinant form of MuSK was injected 
and expressed at ectopic sites in innervated muscle in vivo. Interestingly, at these sites, a full 
complement of postsynaptic proteins accumulated including adult-type AChRs, and local gene 
expression of endogenous MuSK, AChR ε and ErbB receptors was induced [25, 31]. Together, 
results from these two approaches demonstrate that MuSK is part of the functional receptor for 
agrin and that it is both necessary and, upon activation, sufficient to drive postsynaptic assembly 
and at least some aspects of synaptic gene transcription. 
MuSK, however, is itself unable to directly bind to agrin, which represents a parallel to certain 
other RTKs that require co-receptors to bind to their extracellular ligands [30]. Based on this 
observation, it has been proposed that MuSK needs to associate with a myotube-associated 
specificity component (termed MASC; Fig. 1), in order to constitute a fully functional receptor that 
both binds and responds to agrin [30]. Mutational analysis of MuSK suggests that the first, most N-
terminal immunoglobulin-like domain in MuSK’s exodomain (Fig. 2B) interacts with MASC [32], 
but the nature of MASC has remained largely elusive so far. Since α-dystroglycan, a component of 
the dystrophin/utrophin glycoprotein complex (D/UGC), efficiently binds to agrin, this protein 
could in principle be a candidate for MASC. However, agrin fragments that do not bind to α-
dystroglycan still cause AChR clustering and activate MuSK [33-35], and agrin-induced MuSK 
activation is normal in antisense-treated myotubes that express low levels of α-dystroglycan [36]. 
These observations strongly suggest that α-dystroglycan is not the MASC co-receptor for MuSK.  
MASC however may in part originate from post-translational modification of one or several 
synaptic proteins, in particular from glycosylation. This idea stems from the observation that certain 
galactose-based oligosaccharides, including the so-called CT carbohydrate, are concentrated at the 
NMJ [37, 38]. Agrin itself contains the CT carbohydrate, which potentiates agrin's clustering ability 
in myotubes [39]. Also, when heavily glycosylated agrin forms are purified by peanut-agglutinin, 
they do trigger MuSK autophosphorylation in vitro. This activation can be inhibited by adding 
components of the CT carbohydrate, and such components bind to agrin and MuSK in vitro [38]. 
Thus the CT carbohydrate, at least in vitro, can serve a similar role to that proposed for MASC in 
that it can bind to agrin and MuSK and stimulate the MuSK kinase activity.  
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Another important question is how, following stimulation by agrin, MuSK transmits a signal 
into myotubes. In response to agrin, MuSK undergoes autophosphorylation, probably on several 
cytoplasmic tyrosine residues [40]. Such phosphorylated tyrosines could then act as docking sites 
for binding of signal-transducing molecules, in analogy to many other RTKs. Several of MuSK’s 
cytoplasmic tyrosine residues are indeed essential for AChR clustering in response to agrin in 
myotubes, as shown by mutational analysis of MuSK and transfection into MuSK -/- myotubes 
(Fig. 2B). Three of these critical tyrosines reside closely together in the kinase activation loop, 
which illustrates the requirement for MuSK kinase activity in agrin signaling [41]. In agreement 
with this, inactivating MuSK’s kinase activity by mutation of a lysine residue in the ATP-binding 
site also abolishes the AChR clustering activity of MuSK [32]. Another critical tyrosine is located 
close to the membrane and can, along with the sequence surrounding it, actually confer agrin 
responsiveness when expressed in otherwise inactive MuSK-TrkA chimeras [32, 41]. Interestingly, 
the sequence context of this juxtamembrane tyrosine (NPXY; Fig. 2B), corresponds to the 
consensus binding site for PTB- (phosphotyrosine-binding) domains of Shc and related adaptor 
proteins.  
Thus, MuSK signaling depends on MuSK kinase activity and a juxtamembrane domain, which 
is very likely to bind to an important Shc-like protein as downstream mediator. In contrast, the 
extreme C-terminus of MuSK, which contains a consensus-motif for interaction with PDZ-domains, 
is dispensable for clustering of AChRs at least in transfected myotubes, suggesting that binding of 
PDZ-domain proteins to MuSK is not important for this process [32]. Interestingly, cross-linking 
and mass spectrometry recently identified a PDZ-domain-containing protein, MAGI-1c, a member 
of the membrane-associated guanylate kinase protein family, as a protein that interacts with MuSK 
[42]. Whether MAGI-1c binds to the C-terminus of MuSK and what  role it plays in NMJ formation 
is currently unknown; the synaptic location of this protein at the NMJ, however, suggests a role in 
later steps of synapse formation, following AChR clustering. 
 
3.3  Rapsyn is a downstream mediator in AChR clustering 
The agrin signaling pathway downstream of MuSK involves rapsyn as a central player. 
Originally identified as a 43 kD AChR-associated protein in Torpedo synaptic membranes [43-45], 
rapsyn turned out to be necessary for clustering of AChRs and many aspects of postsynaptic 
differentiation in mammalian muscle. Thus, at mutant endplates of rapsyn -/- mice, clusters of 
AChRs and other postsynaptic proteins such as dystroglycan, utrophin or ErbB receptors are 
missing, and the animals die at birth due to failure to breathe [46]. Likewise, myotubes cultured 
from these mutant mice do not form AChR clusters spontaneously nor in response to agrin. MuSK 
is the only postsynaptic protein to still be localized synaptically at mutant NMJs in rapsyn-deficient 
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mice, and MuSK is activated by agrin in cultured rapsyn -/- myotubes, showing that rapsyn acts 
downstream of MuSK [47].  
In agreement with its role in protein aggregation in vivo, rapsyn is able to cluster certain 
postsynaptic markers upon expression in transfected or microinjected heterologous cells in vitro. 
When expressed heterologously, rapsyn organizes itself in small clusters, illustrating an intrinsic 
capability of rapsyn to form aggregates. Upon co-expression in heterologous cells, rapsyn causes 
co-clustering of itself with AChRs, dystroglycan and MuSK [48-51]. Such heterologous expression 
of rapsyn and AChRs was used to determine which domains in both proteins mediate steps in 
rapsyn-induced clustering of the receptor. The protein structure of rapsyn includes, from the N-
terminus, a myristoylation site, several tetratricopeptide repeats (TPR), a coiled-coil motif, a ring 
zinc finger (RING-H2) domain and a serine phosphorylation site (reviewed by [52]; Fig. 2C). 
Whereas myristoylation mediates plasma membrane targeting of rapsyn, at least two of the TPRs 
are necessary and sufficient for rapsyn self-aggregation [53-55]. The coiled-coil motif, in turn, is 
required for co-clustering of AChRs in rapsyn aggregates [54, 55]. With respect to the AChR, 
rapsyn is able to cluster individually expressed single subunits of the receptor, a process which 
requires the intracellular portion of the subunits, as shown for the AChR α subunit [56]. Thus, in 
heterologous cells, rapsyn appears to interact with all AChR subunits; furthermore, self-aggregation 
and AChR clustering are mediated by different domains of the rapsyn molecule.  
Besides the AChR, MuSK and dystroglycan are two postsynaptic proteins that are clustered by 
rapsyn in heterologous cells. Rapsyn directly binds to the cytoplasmic portion of β-dystroglycan 
and this binding is mediated by the RING-H2 domain of rapsyn as shown by biochemical assays, 
interactions in yeast two-hybrid systems and co-clustering in transfected cells [57, 58]. In contrast, 
the association of rapsyn with MuSK does not require the cytoplasmic tail of MuSK, but involves 
the fourth (membrane-proximal) immunoglobulin-like domain in MuSK’s exodomain [32, 47] (Fig. 
2B and 2C). Therefore, the extracellular domain of MuSK may be linked to rapsyn by a rapsyn-
associated transmembrane linker protein (RATL) of as yet unknown identity [47] (Fig. 1), whose 
function may be to recruit rapsyn and its associated proteins to MuSK. Taken together, these studies 
assign different functions to the different modules in rapsyn: while TPR domains mediate rapsyn 
self-aggregation, the coiled-coil region causes AChR clustering and the RING-H2 domain 
clustering of dystroglycan. 
It is worth mentioning that these results are largely based on heterologous protein expression. In 
myotubes, clustering appears to be regulated by additional, myotube-specific mechanisms. This is 
illustrated by the requirement for agrin and MuSK to efficiently cluster AChRs in muscle and by the 
larger size of clusters in myotubes. Furthermore, the expression level of rapsyn is an important 
parameter that determines its ability to mediate agrin-induced AChR clustering in myotubes. In 
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muscle, as well as Torpedo electric organ, endogenous rapsyn occurs in roughly a 1:1 stochiometry 
with the AChR [59, 60]. When rapsyn is overexpressed in myotubes, fewer spontaneous and agrin-
induced AChR clusters are seen than in myotubes expressing physiological levels of rapsyn [61-63]. 
This implies that in muscle, rapsyn aggregation may be regulated by further muscle proteins.  
Moreover, rapsyn may be involved in trafficking of AChRs to the plasma membrane, which is 
supported by the colocalization of rapsyn with AChRs in post-Golgi transport vesicles of Torpedo 
electric organ [64, 65]. The possible role of rapsyn in AChR surface transport is also illustrated by 
myotubes overexpressing rapsyn, in which AChRs accumulate intracellularly in aggregates that 
colocalize with rapsyn [63]. Furthermore, in transfected fibroblasts expressing both rapsyn and 
AChRs, levels of surface AChRs are much lower than in fibroblasts expressing only AChRs [63]. 
These data suggest, in fact, that rapsyn may be a negative regulator of AChR surface transport and 
may thus control expression levels of the receptor at the plasma membrane.  
Finally, unlike in heterologous cells, rapsyn cannot form clusters independently of AChRs in 
myotubes, but requires some sort of association with the receptor to form aggregates. This is 
illustrated by ectopic injection of rapsyn into myofibers in vivo, where this rapsyn does not form 
aggregates, and by downregulation of surface AChRs by anti-receptor antibodies in myotubes; in 
such cells, residual rapsyn does not form agrin-induced clusters [66].  
 
3.4  Src-family kinases and phosphorylation of the AChR β subunit are involved in efficient 
AChR clustering induced by agrin 
Well-known signaling steps downstream of MuSK are tyrosine-phosphorylation of the AChR β 
subunit and a link of the receptor to the cytoskeleton. Recently it has been shown that AChR 
phosphorylation and Src-family kinases are involved in efficient agrin-induced cytoskeletal linkage 
and clustering of the AChR [67-70].  
Agrin-induced tyrosine-phosphorylation of the AChR occurs on its β and δ subunits in cultured 
myotubes and is paralleled by a link of the receptor to the cytoskeleton [68, 71, 72]. Similarly, 
AChRs at developing NMJs are progressively stabilized, most likely through a cytoskeletal link, 
and these junctions contain phosphotyrosine-proteins that codistribute with the receptors [73, 74]. 
Several experimental approaches were used to determine whether agrin-induced clustering and 
cytoskeletal linkage of the AChR require its tyrosine-phosphorylation. For example, herbimycin 
and staurosporine, two inhibitors of tyrosine kinases, block both agrin-induced AChR β and δ 
phosphorylation and clustering [68, 72, 75]. Conversely, pervanadate, an inhibitor of tyrosine 
phosphatases, causes increased AChR phosphorylation and an increased cytoskeletal link of AChRs 
in myotubes [76]. Most importantly, upon transfection into myotubes, mutant AChRs lacking 
cytoplasmic tyrosine residues in their β subunits, although still able to form agrin-induced clusters 
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[77], show a clearly reduced extent of clustering and cytoskeletal linkage [67]. This demonstrates 
that tyrosine-phosphorylation of the AChR β subunit, induced by agrin, regulates the link of the 
AChR to the cytoskeleton and contributes to efficient clustering of the receptors [67]. 
Other strategies have been used to analyze which kinase(s) phosphorylates the AChR following 
treatment of myotubes with agrin and what role such a kinase plays in receptor clustering. AChR 
phosphorylation is unlikely to be the direct result of agrin-activated MuSK, because staurosporine 
blocks phosphorylation (and clustering) of the receptor without interfering with MuSK activation 
[68, 78]. These observations strongly imply the existence of some other kinase(s) downstream of 
MuSK. Accumulating evidence suggests that this kinase(s) is a member of the Src-family. Thus, 
two members of this family, Src and Fyn, interact with AChRs in myotubes [79], whereas Fyn 
together with Fyk (another Src-like kinase) associate with AChRs in the electric organ of Torpedo 
[80]. In agrin-treated myotubes, the Src-like kinases that are bound to the AChR are activated and 
tyrosine-phosphorylated; this activation is abolished by staurosporine and not observed in rapsyn-
deficient myotubes and thus correlates highly with AChR clustering [68]. A fraction of the Src and 
Fyn pool in myotubes also forms a complex with MuSK, and these kinases can phosphorylate 
MuSK and increasingly interact with MuSK following agrin treatment [69]. This suggests, 
interestingly, that the rapid phosphorylation of MuSK in response to agrin, widely thought to reflect 
autophosphorylation, may actually originate from Src-like kinases that are constitutively bound to 
MuSK. Furthermore, PP1, a specific inhibitor of the Src-family, blocks the agrin-induced 
cytoskeletal linkage of the AChR, while expression of dominant-negative, kinase-inactive Src in 
myotubes interferes with clustering induced by agrin, leading to AChR aggregates that are very 
small [69].  
A genetic approach, using doubly-deficient mice lacking both Src and Fyn, tested the role of Src 
and Fyn in postsynaptic differentiation, AChR clustering and phosphorylation more directly [70]. 
These animals die around birth and move and breathe only weakly, consistent with neuromuscular 
failure. However, all aspects of synaptic development examined such as innervation, AChR gene 
expression and clustering of postsynaptic proteins are normal [70]. Likewise, agrin induces normal 
AChR clustering and AChR β phosphorylation in myotubes derived from the doubly-deficient 
mice. However, in these myotubes, the Src-family kinase Yes is upregulated and may thus 
compensate. Most interestingly, after induction of clustering and withdrawal of agrin from these 
myotubes, clusters of AChRs are dramatically less stable than in wild-type cells [70].  
Taken together, these recent data show that kinases of the Src family play a role in agrin 
signaling: a subpopulation of the total pool of these kinases interacts with and phosphorylates 
MuSK in response to agrin, while those Src-like kinases that constitutively bind to the AChR are 
activated by agrin. Furthermore, cytoskeletal linkage of the AChR and growth of AChR clusters 
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involves Src-like kinase functioning. However, Src and Fyn themselves are dispensable for AChR 
clustering and phosphorylation, although in their absence, Yes may compensate. Nonetheless, Src 
and Fyn are clearly required to stabilize agrin-induced AChR aggregates, showing that the 
mechanisms for formation versus stabilization of these clusters are different.  
 
3.5  Postsynaptic pre-assembly: an active role for AChRs, by association with rapsyn, in 
postsynaptic organization 
As detailed above, both MuSK and the AChR interact with Src-family kinases in myotubes. 
Some interaction occurs constitutively, i.e. independent of agrin in both cases, thus revealing the 
existence of pre-assembled protein complexes. Since these Src-related kinases react differently in 
response to agrin, however, interactions with MuSK and AChR appear to originate from two 
distinct sub-populations of Src-family kinases: while agrin causes Src-like kinases to increasingly 
bind to MuSK [69], agrin activates Src-like kinases constitutively associated with the AChR 
without affecting their interaction with the receptor [68]. Further differences between the 
subpopulations of Src-like kinases bound to MuSK and the AChR are illustrated by rapsyn. Rapsyn 
is not necessary for agrin-induced MuSK phosphorylation [47], implying that activation of MuSK-
bound Src-like kinases and Src-mediated phosphorylation of MuSK [69] occurs independently of 
rapsyn. In contrast, rapsyn is required for agrin-induced activation of AChR-bound Src-family 
kinases [68]. These data provide increasing evidence for the existence of two independent pre-
assembled signaling complexes in myotubes, a MuSK-bound complex and an AChR-bound 
complex (Fig. 3).  
Accumulating evidence suggests that these complexes both contribute to postsynaptic assembly, 
thereby providing a step-by-step mechanism for postsynaptic organization. One first key aspect of 
this emerging mechanism is that the MuSK-bound complex acts as a primary synaptic scaffold and 
is clustered first due to agrin; this scaffold then recruits pre-assembled AChR complexes via rapsyn 
(Fig. 3). This concept is based on several observations. First, in the absence of rapsyn, MuSK is the 
only identified postsynaptic proteins that is still clustered postsynaptically, leading to the idea that 
MuSK is a primary synaptic scaffold [47]. Second, in agreement with this, a recombinant 
constitutively active form of MuSK is able, upon ectopic injection in myofibers in vivo, to organize 
postsynaptic specializations containing AChRs and most other postsynaptic components [31]. 
Third, AChRs, dystroglycan and MuSK are co-clustered with rapsyn upon expression in 
heterologous cells [48-51], suggesting that rapsyn recruits other proteins to the MuSK scaffold. 
A second key aspect of this step-by-step mechanism of postsynaptic assembly is that AChRs are 
not passively inserted into a postsynaptic lattice formed by other proteins, but instead play an active 
role themselves in this postsynaptic organization [66, 81, 82]. In particular, AChRs are necessary 
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for clustering of rapsyn (Fig. 3). Thus, in zebrafish mutants lacking functional AChRs, NMJs are 
formed and appear ultrastructurally normal [83], but lack synaptic rapsyn [82], showing that AChRs 
are required for synaptic accumulation of rapsyn. Similarly, upon ectopic injection into myofibers 
in vivo, rapsyn cannot form clusters in the absence of AChRs [66]. In cultured myotubes, AChRs 
interact with rapsyn (and some other postsynaptic proteins) independently of agrin [84], illustrating 
the presence of pre-assembled rapsyn-AChR complexes. Some of these complexes are observed 
intracellularly, but most of them reside in a diffusely distributed form in the myotube plasma 
membrane [66] (Moransard and Fuhrer, unpublished data). Rapsyn can also interact with 
unclustered AChRs in extrasynaptic areas of denervated diaphragm in vivo (Moransard and Fuhrer, 
unpublished data). Most importantly, rapsyn-AChR complexes at the surface are essential for 
clustering, because upon downregulation of surface receptors by AChR-antibodies in myotubes, 
residual rapsyn cannot form agrin-induced clusters but redistributes along with the AChR [66]. This 
antibody treatment affects the cellular level of rapsyn roughly half as much as the level of AChRs, 
suggesting that about 50% of the total rapsyn is complexed with the AChR while the rest represents 
free rapsyn [66]. 
These data change the traditional view that rapsyn forms clusters first and then recruits AChRs 
into such clusters. Instead, rapsyn is not able to aggregate independently of the AChR in muscle but 
requires association with the AChR in pre-assembled complexes to form agrin-induced clusters in 
myotubes. Rapsyn may act in clustering by increasingly binding to AChRs and linking such 
receptors to the cytoskeleton, because agrin triggers increased interaction of rapsyn with 
unclustered surface AChRs in myotubes. Such an increase correlates highly with AChR clustering, 
and, when analyzed by a differential extraction assay [67] those receptors that increasingly interact 
with rapsyn are increasingly bound to the cytoskeleton (Moransard, Ferns and Fuhrer, unpublished 
data).  
AChRs are also involved in clustering of other postsynaptic proteins in myotubes (Fig. 3). In 
variants of C2 lacking AChRs, and in C2 treated with anti-AChR antibodies to downregulate 
surface receptors, rapsyn, dystroglycan, syntrophin and acetylcholinesterase cannot form agrin-
induced clusters, while clustering of MuSK, dystrobrevin and utrophin is unchanged [66, 85]. The 
absence of clusters of acetylcholinesterase under these circumstances [85] fits well with its binding 
to perlecan, which in turn interacts with dystroglycan (Fig. 1; [86, 87]). Strikingly, many of the 
proteins that require AChRs to form agrin-induced clusters in cultured myotubes (i.e. rapsyn, 
dystroglycan and syntrophin) are co-transported with AChRs to the postsynaptic membrane in post-
Golgi transport vesicles in Torpedo electric organ [65]. Dystrophin and dystrobrevin are not found 
on these vesicles and thus reach the postsynaptic membrane independently of AChRs and the 
secretory pathway in Torpedo [65], in analogy with the AChR-independent clustering of utrophin 
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and dystrobrevin in cultured myotubes [66]. These data strongly suggest that cotransport of rapsyn, 
dystroglycan and syntrophin with the AChR through parts of the secretory pathway is a requirement 
for subsequent agrin-driven clustering at the surface. This role of AChRs in clustering of other 
proteins is paralleled by biochemical demonstrations of pre-assembly of the AChR with other 
postsynaptic proteins including MuSK, Src-family kinases, dystroglycan and utrophin 
independently of agrin [84]. Such complexes appear to be linked to MuSK - presumably  the MuSK 
primary synaptic scaffold -  in response to agrin, leading to a rapsyn-dependent increase in the 
AChR-MuSK interaction, whereas other AChR-protein interactions are not affected by agrin (Fig. 
3) [84].  
In addition, once NMJs are formed, AChRs are required to maintain the synaptic density of 
several postsynaptic proteins [88]. In AChR ε subunit-deficient mice at two months of age, AChRs 
and rapsyn are strongly reduced in parallel at NMJs whereas agrin, dystrobrevin and utrophin are 
still efficiently clustered [89]. Thus, the synaptic densities of dystrobrevin and utrophin, but not 
rapsyn, can be regulated independently of AChRs at agrin-containing NMJs, similarly to clustering 
of these proteins in agrin-treated myotubes lacking aggregated AChRs [66]. 
The emerging picture is that AChRs play an active and early role in postsynaptic assembly, at 
least in part by forming pre-assembled complexes with other postsynaptic components. Moreover, 
AChRs are required later in development in order to maintain the integrity of the postsynaptic 
apparatus. 
An important consequence of these studies is that formation of a postsynaptic apparatus can 
occur by pre-assembly of neurotransmitter receptors with scaffolding proteins. This concept of 
postsynaptic pre-assembly may well apply also to synapses in the central nervous system. At 
excitatory synapses, pre-assembly, although not shown on a biochemical level, has been proposed 
based on hippocampal neurons where clusters of PSD-95 first appear in dendritic shafts or dynamic 
spine precursors before moving to their final position in the mature spine head [90]. Furthermore, at 
inhibitory synapses, much like AChRs and rapsyn at the NMJ, gephyrin and GABAA-receptors are 
mutually important for clustering [91], most likely by forming interdependent components of a 
protein complex. Postsynaptic pre-assembly is an interesting parallel to the more established 
observations that presynaptic components of the nerve terminal are transported together in packets 
along axons, reflecting pre-assembled active zone precursors [92, 93]. Thus, both pre- and 
postsynaptic specializations of synapses may be constructed from pre-assembled complexes of their 
components; such pre-assembly may ensure that pre- and post-synaptic membranes can be formed 
and modified rapidly according to physiological needs.  
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3.6  Calcium, GTPases and nNOS are further signaling intermediates in agrin-induced AChR 
clustering  
Given the complexity of the postsynaptic apparatus and its plasticity during embryonic and 
early postnatal development, the mechanism of agrin-induced postsynaptic assembly (Fig. 3) is 
likely to be subject for regulation by further signaling intermediates. Inhibition of agrin-induced 
AChR clustering by a fast chelator, BAPTA-AM, has indeed shown that Calcium fluxes are 
required for receptor aggregation in cultured myotubes [94, 95].  
AChR clustering in myotubes also depends on the small GTPases, Rac and Cdc42, because 
dominant-negative forms of these signaling molecules inhibit aggregation of AChRs in transfected 
myotubes [96]. A role of these GTPases in agrin signaling is also indicated by the activation of one 
of their downstream kinases, c-Jun NH2-terminal kinase (JNK), by agrin [96]. In other signaling 
systems, JNK, via phosphorylation of c-Jun, is known to induce expression of target genes, while 
Rac and Cdc42 can control actin polymerization, thereby causing focal reorganization of the actin 
cytoskeleton in response to extracellular cues. F-actin assembly is indeed required for AChR 
aggregation, because latrunculin A inhibits agrin-induced AChR clustering in cultured Xenopus 
muscle cells [97]. Together, these data show that Rac and Cdc42 activation is required for receptor 
clustering, most likely via controlled reorganization of the actin cytoskeleton. It remains unclear, 
however, how F-actin acts in AChR clustering. Although utrophin is an actin-binding protein, 
utrophin itself is dispensable for receptor aggregation [98], implying that actin acts through other 
binding proteins. 
Another signaling intermediate recently found to be important in AChR clustering is nitric 
oxide, NO [99]. The enzyme producing NO, neuronal nitric oxide synthetase (nNOS), was known 
for several years to be concentrated at NMJs, through binding to isoforms of syntrophin, 
components of the D/UGC (Fig. 1) [1]. Recent reports indicate that nNOS is co-aggregated with 
AChRs in cultured myotubes treated with agrin [100]; furthermore, NO is a messenger and is 
required in agrin-induced AChR clustering and AChR β phosphorylation as shown by NOS 
inhibitors and NO donors [99]. Although the downstream targets of NO are not known at this point, 
they could in principle involve Src-family kinases because these are activated by NO in fibroblasts 
[101]. The idea of NO-mediated Src-family activation in muscle is particularly attractive because of 
the activation of Src-family kinases by agrin in myotubes and their role in stabilization of AChR 
clusters [68, 70]. 
 
3.7  Neuregulin-1 is a key factor for AChR gene expression 
Apart from redistribution of existing proteins by agrin, the high synaptic density of NMJ 
components, particularly of the AChR, is also achieved through a specific upregulation in the 
 14
transcription of their genes in subsynaptic nuclei. This activity originates at least in part from 
neuregulin-1, a protein expressed by motorneurons and skeletal muscle which is concentrated at the 
NMJ [3, 102]. Neuregulin-1 is a member of the neuregulin gene family and was first isolated from 
chick brain as "AChR-inducing activity" (ARIA), because of its ability to induce transcription of 
AChR subunits in myotube cell cultures (reviewed by [102]). In heterozygous mice lacking one 
copy of the neuregulin-1 gene, the AChR density at the endplate is reduced and the mice are 
myasthenic [103], showing that neuregulin-1 is indeed required to maintain high receptor density in 
vivo.  
The pathway leading from neuregulin-1 to gene expression is now clarified to some extent [104, 
105]. Neuregulin-1 binds and activates ErbB receptor tyrosine kinases (ErbB2-4) which are 
expressed by muscle and concentrated at the NMJ [106, 107]. Since ErbB3 is detected in 
presynaptic Schwann cells while ErbB2 and ErbB4 are found in the postsynaptic muscle membrane, 
the functional receptor for neuregulin-1 to signal postsynaptic gene transcription is likely to be a 
combination of ErbB2 and ErbB4 [108]. Like MuSK, ErbB receptors belong to the class of receptor 
tyrosine kinases, characterized by autophosphorylation on intracellular tyrosine residues upon 
ligand binding. ErbB receptors trigger a signaling cascade that involves recruitment of the adapter 
proteins Grb2 and Shc and activation of Ras, Raf and ERK, a subgroup of the MAP kinase family 
[109-112]. Still controversial is the role of PI3-kinase in this pathway, since interaction of this 
kinase with ErbB receptors does occur in muscle cells, but it is not clear whether its activity is 
required for AChR subunit expression [110, 112]. ERK ultimately regulates the transcription of c-
Jun and c-Fos transcription factors that represent the major components of the transcription factor 
AP-1 [113]. JNK, another member of the MAP kinase family that regulates the function of c-Jun, is 
also activated by neuregulin-1 in muscle cell cultures and required for neuregulin-1-induced AChR 
transcription [113]. Together, these studies indicate that neuregulin-1 activates multiple signaling 
cascades that converge to regulate the transcription of AChR subunits (Fig. 4). Since c-Jun 
functioning is essential in this process but possible targets such as the AChR ε subunit gene lack the 
consensus sequence for AP-1 binding [113], the transcription of AChR subunits seems to ultimately 
be driven by transcription factors other than AP-1. Indeed, members of the Ets family of 
transcription factors such as GABP α and GABP β bind to N-box motifs in the regulatory region of 
the AChR subunit genes and this mechanism drives synaptic AChR transcription [114-118]. The 
evidence for GABP being a critical transcription factor for synaptic AChR expression fits well with 
the observations that Ets-family transcription factors are classical targets for MAP kinases and that 
such kinases (for example ERK) are activated by neuregulin-1 [105].  
ErbB signaling is under more complex regulation than implied from the studies summarized 
above. First, besides kinases, the protein tyrosine phosphatase SHP2 is also involved in the 
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regulation of the neuregulin-1 pathway. An initial indication for this was the increased expression 
of AChR ε subunits in myotubes treated with the phosphatase inhibitor orthovanadate [119]. Later, 
SHP2 was found to interact with ErbB receptors through its SH2 domain and to act as a negative 
regulator in the pathway by keeping low the number of phosphorylated tyrosines on ErbB receptors 
[120]. This implicates a possible role for SHP2 in limiting the number of ErbB-interaction partners, 
thereby selecting the outcome of the signaling cascade.  
Second, the cycline-kinase Cdk5, a serine kinase, is activated by neuregulin-1 in muscle cells 
[121]. On the other hand, Cdk5-activity is necessary for neuregulin-1-induced activation and 
autophosphorylation of ErbB receptors. One explanation for this observation is that a basal level of 
Cdk5 activity is always present that keeps ErbBs in a "primed" state and that binding of neuregulin-
1 increases ErbB kinase activity [121]. This, in turn, further activates Cdk5, thereby leading to a 
positive feedback loop onto ErbBs themselves (Fig. 4).  
Besides AChRs, mRNAs encoding other synaptic proteins are concentrated at the NMJ 
including acetylcholinesterase, MuSK, rapsyn, laminin-β2 and N-CAM [28, 122-124]. For some of 
these, for example acetylcholinesterase, utrophin or MuSK, N-box motifs have been reported in the 
regulatory regions of their genes [25, 125, 126]. In the case of acetylcholinesterase, N-box motifs 
are indeed required for its synaptic expression in vivo [126]. Utrophin, in turn, is increasingly 
expressed in response to neuregulin-1 through the GABP/N-box pathway [125]. This suggests that 
this pathway regulates the synaptic expression of several proteins, not only AChRs. Since not all 
synaptically expressed genes have been reported to contain N-boxes, however, other pathways are 
likely to exist and to regulate synaptic gene expression at the NMJ.  
 
3.8  Interaction between the neuregulin and agrin signaling pathways 
Interestingly, a growing body of evidence suggests that the agrin and neuregulin-1 signaling 
pathways, which both contribute to the high synaptic density of AChRs at the NMJ, are linked and 
that agrin acts upstream of or in parallel with neuregulin-1, by using a cross-talk with the 
neuregulin-1 pathway that ultimately allows agrin to increase the expression of AChRs. Of crucial 
importance for this was the initial observation that agrin, when presented to cultured myotubes in a 
substrate-bound form, is not only able to cluster pre-existing AChRs but also to induce new 
expression of AChR ε subunits [127]. Upon ectopic injection of agrin cDNA into adult muscle, 
agrin was then found to cause local transcription of AChR ε subunits in vivo [22, 24]. Furthermore, 
such injected agrin causes clustering of neuregulin-1 and ErbB receptors (along with AChRs and 
many other postsynaptic proteins) [21, 23] and also induces local transcription of MuSK and ErbBs 
[25]. Following ectopic injection of wild-type or constitutively active recombinant MuSK, AChR ε 
transcripts are likewise produced around the injection site [31, 128].  
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Interestingly, agrin-induced AChR ε transcription in both cultured myotubes and ectopically 
injected myofibers is dependent on signaling through ErbB2, as shown using dominant-negative 
ErbB2 expression and conditional homologous recombination, respectively [25, 129]. Conversely, 
neuregulin-1 induces the expression of MuSK mRNA in cultured myotubes [130]. This strongly 
implies a feedback loop between ErbBs and MuSK, in that the agrin/MuSK pathway stimulates 
ErbB transcription while the neuregulin-1/ErbB pathway triggers enhanced MuSK transcription 
(Fig. 4).  
Another level of cross-talk between the two pathways comes from the observations that in the 
agrin -/- mice, ErbBs are no longer clustered at the mutant synapses of these animals [18] and that 
ectopically expressed agrin causes clustering of muscle-derived neuregulin-1 and ErbBs as 
mentioned above. This implies that agrin organizes the neuregulin-1 pathway by causing clustering 
of its major components (Fig. 4). This may also involve direct binding of agrin to neuregulin-1 as 
shown in vitro [129]. The neuregulin-1 involved in AChR cluster formation may be entirely 
muscle-derived, because nerve-derived neuregulin-1 is not required for AChR gene transcription in 
vivo (see below, [10]) and because extracts of muscle cells show neuregulin-1-like biological 
activity as demonstrated by tyrosine phosphorylation of ErbB2 in cultured myotubes [129]. 
Finally, interaction between the agrin and neuregulin-1 pathways is also found on the level of 
JNK, because agrin requires Rac and Cdc42 for AChR clustering and this pathway leads to 
activation of JNK [96], a kinase which is also essential for neuregulin-1 signaling.  
The emerging picture, thus, is that agrin acts as a master organizer of the NMJ by activating its 
own MuSK-based signaling pathway and by organizing, through aggregation, the neuregulin-1 
pathway which can be entirely derived from the muscle (Fig. 4). Through multiple levels of cross-
talk, however, both the agrin and neuregulin-1 signals appear important to lead to full 
differentiation of the NMJ including synaptic transcription of many of its components. 
 
3.9  AChR clustering in the absence of motorneurons 
Much evidence over the last decade pointed out a key role of nerve-derived agrin in clustering 
of AChRs on the muscle surface. As detailed above, crucial observations for this were that in agrin -
/- mice no nerve-bound AChR clusters are present in myofibers at E18.5 and that ectopic injection 
of agrin into myofibers in vivo induces formation of a postsynapse-like apparatus.  
However, this agrin-centered view of synapse formation ignores some early experiments that 
showed AChR clusters aligned in the central portion of embryonic mouse muscle fibers that were 
rendered aneural by treatment with β-bungarotoxin [131, 132]. In this model, it was difficult to 
establish whether the neurotoxin treatment had actually eliminated motorneurons and their contacts 
with the muscle completely. The results, though, have to be reconsidered in view of several recent 
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studies that show that clustering of AChRs can occur in the complete absence of motorneurons in 
the central portion of myofibers in vivo [8-10].  
A strong indication for nerve-independent AChR clustering first came from the analysis of mice 
lacking DNA topoisomerase II β, in which motorneurons do not invade or branch on the diaphragm 
or limb muscles, while AChRs are still clustered in the central portion of these myofibers at E18.5 
[8]. Yet, in these mice nerves grow close to muscles, leaving open the possibility that a short 
contact may take place or that nerve-derived agrin may diffuse into the close vicinity of muscle 
fibers. Therefore, mice lacking the transcription factor HB9 were used that fail to differentiate many 
motorneurons so that the phrenic nerve is completely absent and the diaphragm never innervated. 
Strikingly, also in these HB9 -/- animals, AChRs along with acetylcholinesterase are clustered in 
the central portion of muscle fibers, although in a wider band than in the wild-type; these aneural 
clusters of AChRs are seen at E14.5 and are maintained through E18.5 [9, 10]. Furthermore, in the 
agrin -/- mice, abundant clusters of AChRs and acetylcholinesterase are observed in the central 
portion of diaphragm muscle at E14.5 [9, 10]. By E18.5, these clusters are much reduced in number 
and size, confirming earlier observations in these agrin -/- animals [18, 19]. This represents a  
contrast to HB9 -/- mice, where AChR clusters are present in abundance at E18.5 [9, 10]. Finally, in 
wild-type diaphragm at E14.5, AChR clusters appear in the central endplate zone of muscle fibers 
but many of these clusters are at a distance from the nerve and not opposite to a nerve ending, while 
at E18.5, AChR clusters are strictly nerve-bound [9].  
Interestingly, in aneurally cultured myotubes, spontaneous AChR clusters are formed and 
several postsynaptic proteins interact with the AChR independently of neural agrin as described 
above [84]. This shows that myotubes have the intrinsic ability to pre-assemble AChR protein 
complexes in the absence of motorneurons, a striking parallel to the capability of fetal muscle to 
cluster AChRs and other proteins independently of neural input (see above).  
Together, these studies show that, first, motorneurons and their secreted factors are not required 
for clustering of synaptic proteins in the central endplate zone of muscle fibers at E14.5, the time of 
the earliest contact between nerve and muscle in normal development. Second, a cooperation must 
exist between a cluster-maintaining system driven by neural agrin and a cluster-disrupting system 
driven by other nerve-released factors, because AChR clusters disappear at E18.5 if the nerve is 
present but neural agrin is missing (in agrin -/- mice), and the clusters are maintained if the nerve is 
also absent (in HB9 -/- mice). The nature of the nerve-released cluster-disrupting factor remains 
elusive. However, a good candidate is acetylcholine and evoked electrical activity in the muscle, 
because these factors are well-known to downregulate AChR synthesis in extrasynaptic nuclei 
(reviewd by [1]). The emerging picture is that muscle fibers undergo a program of pre-patterning 
even in the absence of motorneurons, so that AChR are clustered independently of neurons and 
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agrin in a central end-plate zone of the muscle [133, 134]. This pre-patterning is refined by nerve 
contact in that neural agrin stabilizes nerve-bound clusters and induces new clusters, while another 
signal, perhaps acetylcholine leading to electrical muscle activity, disperses clusters that are farther 
away. Together, these mechanisms cause refinement and compacting of the central endplate zone 
bearing AChR clusters, leading to AChR clusters that are precisely located underneath the nerve 
terminal as seen at E18.5 and thereafter.  
Besides lacking neural agrin, aneural muscle also lacks nerve-derived neuregulin-1. 
Surprisingly, mRNAs encoding the AChR α and δ subunits are concentrated in the central endplate 
zone of muscle fibers in HB9-deficient mice although on a wider band than in the wild-type, 
similarly to AChR clusters [9, 10]. Furthermore, in mice where neuregulin-1 is selectively 
inactivated in sensory and motor neurons to circumvent the lethality at E10.5 of neuregulin-1-null 
mice, AChR α and δ mRNAs are concentrated in the middle of muscle fibers like in the wild-type 
[10]. Thus, nerve-derived neuregulin-1 is not required for synaptic AChR transcription at E14.5 and 
E18.5, nor for refining the zone of AChR expression.  
These results strengthen the previous suggestion (see above) that muscle-derived neuregulin-1 
may elicit to some degree the expression of synaptic proteins like the AChR. Thus neural agrin 
seems sufficient to induce AChR transcription by initiating a muscle-intrinsic neuregulin-1/ErbB 
receptor pathway. It cannot be excluded, however, that another signal, unrelated to neuregulin-1, 
regulates AChR transcription in the absence of neural neuregulin-1. 
 
3.10  MuSK is required for nerve-independent AChR clustering 
Nerve-independent clustering of AChRs in the central endplate zone of the muscle raises the 
questions of how such clusters are assembled and how their formation, in the process of muscle pre-
patterning, is limited to the middle of myofibers, although to a significantly wider area than in the 
presence of the nerve.  
Cluster assembly at early (E14.5) and later (E18.5) stages was shown to depend on MuSK and 
rapsyn, because in both MuSK -/- as well as rapsyn -/- mice no AChR clusters are present at these 
stages [9, 10, 46]. Furthermore, in HB9-MuSK double mutants, no AChR clusters or AChR α 
subunit-mRNAs are seen in the central endplate zone of the muscle [9, 10]. Thus, MuSK is required 
for nerve-independent synaptic gene transcription, and MuSK and rapsyn are necessary for AChR 
clustering in the absence of motorneurons. The signaling machinery that drives early aneural AChR 
clustering is therefore similar if not identical to that used by neural agrin at later developmental 
stages. This raises the issue of how MuSK signaling is initiated at the earliest synapses in the 
absence of neural agrin. Mice lacking all forms of agrin, including the muscle isoforms, show the 
same NMJ phenotype as mice specifically lacking only neural agrin [9], implying that it is not 
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muscle-derived agrin that activates MuSK early in NMJ formation. The possibility thus remains that 
at this stage MuSK activation is achieved through other ligands or due to spontaneous self-
activation. Agrin-independent MuSK activation has indeed been shown upon overexpression of 
MuSK or coexpression of MuSK with rapsyn in heterologous cells [40, 47, 49]. Most telling, upon 
ectopic injection into myofibers in vivo, MuSK constructs lacking the ligand-binding extracellular 
domain are able to elicit AChR transcription and clustering even in a MuSK-conditional-knockout 
background, showing that no ligand binding is required for MuSK's synaptogenic activity in this 
paradigm [128].  
Regarding the question of how AChR clusters are limited to the central endplate zone of the 
muscle, one interesting possible explanation takes into consideration the differences in the 
developmental state along muscle fibers [133-135]. Myotubes grow from the middle longitudinally 
by fusion of myoblasts at their ends. Therefore, nuclei and basal lamina in the central part of fibers 
could be ahead in their differentiation state with respect to the more distal parts. As MuSK and 
rapsyn are necessary for central AChR clustering, such clustering may be initiated at sites where 
these and other proteins are expressed a higher levels, that is, in the center of myofibers.  
Muscle pre-patterning could in principle also involve components of the extracellular matrix, in 
particular laminins. In cultured myotubes, AChR clustering can be induced by laminin-1 and 
laminin 2/4 (merosin) [136-138], forms of laminin that are all expressed in the muscle at the earliest 
stages of NMJ formation [139]. Interestingly, laminin-1 activates a signaling pathway that requires 
tyrosine kinases downstream of MuSK as well as rapsyn to cluster AChRs in myotubes; this 
signaling mechanism thus overlaps with that of agrin strongly [165]. Laminins may thus pre-
activate myofibers by activating tyrosine kinases, and such signaling could be involved in agrin-
independent AChR clustering and pre-patterning at E14.5. This mechanism could in principle 
involve MuSK activation through phosphorylation via the laminin-activated downstream kinases. 
Three observations are consistent with such a model. First, MuSK can indeed be phosphorylated by 
other kinases such as Src and Fyn in cultured myotubes [69]. Second, laminin-induced AChR 
clustering occurs at a lower rate in cultured MuSK -/- myotubes than in wild-type cells [136]. Third, 
in ectopic injection experiments in myofibers in vivo, the MuSK kinase domain but not extracellular 
domain is required to induce AChR transcription and clustering [128].  
 
4 Stabilization of AChR clusters and postsynaptic maturation 
 
Neuromuscular synaptogenesis not only involves initial formation of the NMJ during late 
embryogenesis but also synaptic maturation, particularly in the first weeks and months after birth. 
At birth, muscle fibers are multiply innervated and several nerve terminals are intermingled over the 
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postsynaptic apparatus in which clustered AChRs are homogeneously arranged in a flat 
postsynaptic membrane [1, 6]. After birth, activity-dependent mechanisms lead to the process of 
synaptic elimination, in which all but one nerve terminal disappear from the synaptic contact [140]. 
At the same time, the postsynaptic membrane dramatically changes its morphological appearance, 
in that postsynaptic folds are formed causing segregation of some proteins to become concentrated 
either at the crests or in the troughs of these folds [6, 141]. Sodium channels, for example, reside in 
the troughs while AChRs are found at the crests where they closely colocalize with the nerve 
endings. As a result, AChR clusters and nerve terminals adopt a pretzel-like morphology at adult 
NMJs [6, 141].  
Recent studies indicate that synaptic components of the D/UGC, while largely dispensable for 
initial AChR clustering, are required for this process of postjunctional fold formation as well as for 
consolidation and stabilization of AChR clusters. Furthermore, several tyrosine kinases are as well 
necessary for maintenance of AChRs in clusters.  
 
4.1  The D/UGC stabilizes AChR clusters and is required for postnatal maturation of the 
postsynaptic membrane 
Since myofibers undergo contractions, their plasma membrane must be stabilized to withstand 
mechanical stress, and this is the major role of the D/UGC, which links the muscle cytoskeleton to 
the extracellular matrix [142]. Accordingly, when components of this complex are damaged or 
missing, a phenotype often observed is muscular dystrophy [143]. Roles of the D/UGC at the 
synapse were for a long time less obvious than this general role of muscle membrane stabilization. 
However, molecular cloning in combination with detailed immunocytochemical analysis revealed 
that while some components of the D/UGC are found along the muscle fibers, others are highly 
concentrated at the NMJ, thus giving raise to synaptic and extrasynaptic variants of the D/UGC. For 
example, utrophin, β2-syntrophin and α-dystrobrevin-1 are highly concentrated at NMJs and 
virtually absent from extrasynaptic areas, whereas α-syntrophin, α-dystrobrevin-2, α- and β-
dystroglycan and dystrophin are found both at NMJs and extrasynaptic areas [144-146] (Fig. 1). 
This shows that some components of the D/UGC are strongly enriched at the NMJ and recent 
progress has now revealed, largely using gene targeting, that several synaptic components of the 
D/UGC play a role in stabilization of AChRs in clusters and formation of postjunctional folds.  
Utrophin and dystrophin, two homologous proteins, are the largest D/UGC components and 
together necessary for muscle fiber integrity but largely dispensable for NMJ formation. Thus, mice 
lacking utrophin appear surprisingly healthy and have functional NMJs at which AChR densities 
and postjunctional folding are slightly reduced [98, 147]. Similarly, NMJs of mdx mice that lack 
functional dystrophin are largely normal apart from a reduction in postsynaptic folds. This reduced 
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folding may be the consequence of muscle fiber necrosis and cycles of regeneration rather than 
originating from the absence of functional dystrophin protein per se [148, 149]. These results raise 
the possibility of compensation between utrophin and dystrophin in the maintenance of myofiber 
integrity, and indeed mice lacking both dystrophin and utrophin develop a severe muscular 
dystrophy closely resembling human Duchenne muscular dystrophy [150, 151]. Because NMJs are 
remarkably normal even in these doubly-deficient mice and only show reduced densities of AChRs 
and postsynaptic folding, the D/UGC as such appears dispensable for initial formation of the NMJ 
and AChR clusters, but critical for their maturation, in particular formation of postsynaptic folds.  
A more critical role in consolidation and maintenance of AChR clusters and the NMJ is played 
by dystroglycan. To circumvent the early lethality of dystroglycan -/- mice, chimaeric mice were 
generated that lack dystroglycan in selected striated muscle fibers [152]. Such dystroglycan-
deficient myofibers develop severe muscular dystrophy in the first months after birth, and in the 
adult NMJs are fragmented and lack the typical high density of AChRs and acetylcholinesterase 
[152]. The fibers also show a wider distribution of AChR clusters, with a corresponding increase in 
the size of the nerve terminal at the mutant NMJs [153]. In cultured dystroglycan -/- myotubes, 
agrin induces pronounced clustering of AChRs but many other D/UGC components such as 
utrophin, α-dystrobrevin, laminin chains, perlecan and acetylcholinesterase are not found at these 
clusters in contrast to the wild-type [153, 154]. In the cultured dystroglycan -/- myotubes, similarly 
to the aberrant NMJs of the chimaeric mice in vivo, the AChR clusters induced by agrin occupy a 
larger area, appear fragmented and actually consist of many microclusters [153, 154]. Most 
dramatically, these clusters disperse very rapidly after withdrawal of agrin from the culture medium 
[153]. Formation of normal AChR clusters is also compromised in antisense derivatives of C2 
myotubes expressing low amounts of dystroglycan, while agrin-induced phosphorylation of MuSK 
and AChR β subunits is normal in these derivatives [36]. Taken together, these data indicate that 
dystroglycan is required for the integrity of the D/UGC and serves as a membrane anchor to recruit 
components of the complex to the plasma membrane. Although dystroglycan is not a co-receptor 
for MuSK, it is necessary for consolidation of AChR microclusters into aggregates of normal size as 
well as for stabilization of pre-formed AChR clusters and of the NMJ.  
α-Dystrobrevin plays a similar role as dystroglycan in that it is also necessary to stabilize AChR 
clusters. In mice lacking a functional gene for α-dystrobrevin, muscular dystrophy is observed 
which may originate in part from the absence of D/UGC-linked signaling by nNOS, which normally 
interacts with dystrobrevin indirectly [155] (Fig. 1). Initial NMJ formation proceeds relatively 
normally in these animals, but after birth, maturation of the NMJ is strongly affected, as the number 
of postsynaptic folds is reduced and AChRs are found at crests as well as in troughs of these folds, 
and because AChR clusters become fragmented in older α-dystrobrevin -/- animals [154]. Synaptic 
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localization of α- and β2-syntrophin and nNOS is selectively reduced at the mutant endplates. In 
mutant myotubes in tissue culture, AChRs form clusters after addition of agrin, but these clusters 
disappear rapidly upon removal of agrin [154]. Thus, dystrobrevin is required for maintenance of 
clusters of the AChR both in vivo and in vitro, and plays a role in postsynaptic folding and 
segregation of AChRs between crests and troughs.  
Structurally abnormal NMJs are also observed in the absence of α-syntrophin [156]. In mice 
with an inactivated α-syntrophin gene, muscle fibers appear healthy histologically and the mice are 
mobile and fertile [157]. At the NMJs of these animals, utrophin and nNOS are absent, densities of 
AChRs and acetylcholinesterase are reduced and abnormal postsynaptic folds with fewer openings 
to the synaptic cleft are observed [156]. Thus, α-syntrophin causes synaptic localization of utrophin 
and nNOS which may explain some of the similarities in the NMJ phenotype between α-syntrophin 
-/- and utrophin -/- mice. 
 
4.2  A role for tyrosine kinases in stabilization of AChR clusters induced by agrin 
Several studies have recently shown that besides the D/UGC, stabilization of agrin-induced 
AChR clusters in myotubes requires tyrosine kinases. First, the kinase inhibitors herbimycin and 
staurosporine disperse pre-formed AChR clusters after removal of agrin from myotubes [72], 
showing that tyrosine kinase activity is necessary to maintain AChR clusters. Since staurosporine 
does not affect the phosphorylation status of MuSK [78], the critical kinase activity for cluster 
stabilization seems to originate from a kinase other than MuSK.  
Second, although dispensable for AChR clustering, Src together with Fyn are necessary for 
stabilization of AChR clusters, as shown in myotubes derived from Src-Fyn-doubly deficient mice: 
in such cultures, agrin-induced AChR clusters disappear rapidly after removal of agrin from the 
culture medium [70]. Although performed in cell culture, these studies seem relevant also for NMJ 
development in vivo, because results from dystroglycan -/- and α-dystrobrevin -/- myotubes in 
culture (see above) are strictly in agreement with the observed alterations at the NMJs in vivo in 
these mice: in both experimental setups (cultured myotubes vs. NMJs in vivo), the stability of 
clustered AChRs is compromised. Interestingly, the stability of AChR clusters in myotubes is not 
affected by the Src-family inhibitors PP1 and PP2, suggesting that the kinase activities of Src and 
Fyn are not primarily required for cluster maintenance [70]. These observations reveal a parallel to 
focal adhesion sites, where Src, independent of its kinase activity, can recruit and activate other 
proteins such as focal adhesion kinase (FAK) [158, 159]. At the NMJ, thus, Src and Fyn may act at 
least in part as adapters, by recruiting other proteins including kinases in order to stabilize AChR 
clusters.  
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Third, the receptor tyrosine kinase TrkB is also involved in cluster stabilization. Overexpression 
of a dominant-negative TrkB form leads to disruption of TrkB-initiated signaling  and to a decrease 
in the stability of AChR clusters both in vivo and in agrin-treated myotubes in culture [160]. Since 
TrkB is concentrated in the postsynaptic membrane at the NMJ and can associate with Fyn in 
cortical neurons [160, 161], TrkB may interact with Src-family kinases also in muscle and act 
through these kinases, offering an explanation why AChR clusters are unstable when Src and Fyn 
are absent or when TrkB signaling is affected. The ligand for TrkB triggering cluster stabilization is 
not known at this point. Although BDNF is a prominent ligand of TrkB, BDNF actually inhibits 
agrin-induced AChR clustering in cultured myotubes, similarly to the effects of NT-4 [162]. This 
raises the possibility that TrkB may exert two different effects at the neuromuscular synapse, 
depending on the stage of NMJ differentiation. While early in postsynaptic assembly it may 
negatively regulate AChR clustering (triggered by BDNF), it may later stabilize the postsynaptic 
membrane. 
Taken together, several tyrosine kinases (Src, Fyn and TrkB) are necessary for stabilization of 
clusters of the AChR. It remains to be investigated how these kinases act in this process. One 
attractive possibility is that they ultimately direct a link of the AChR to the D/UGC, because this 
protein complex is - like Src, Fyn and TrkB - essential in cluster maintenance (see above). Such a 
link may involve dystrobrevin, because this protein is a substrate for tyrosine kinases and heavily 
phosphorylated in Torpedo electric organ [163]. Although α-dystrobrevin is not phosphorylated by 
short agrin treatments of myotubes in culture [145], its phosphorylation may play a role in 
stabilization of AChR clusters at the developing NMJ in vivo.  
 
4.3  AChRs themselves are required for postsynaptic stabilization and postnatal maturation 
Besides synaptic elimination and formation of postjunctional folds, the development of the NMJ 
after birth includes a change in the composition of the AChR itself, as the embryonic γ subunit is 
replaced by the adult ε subunit. The role of AChRs in this phase of NMJ development was studied 
by deleting the ε gene in mice [88, 164]. In AChR ε -/- mice, neuromuscular synaptogenesis 
proceeds normally until the first weeks after birth, when normally the γ subunit is replaced by ε. 
Since the mice downregulate γ but cannot synthesize ε, they fail to produce functional AChRs in 
high enough amounts to keep the NMJ healthy. Instead, the high postsynaptic density of AChR seen 
at birth is gradually reduced in the first weeks after birth, leading to gradual muscle weakness and 
atrophy and premature death in the mutants [88, 164]. Interestingly, postjunctional folds disappear 
along with the AChR, such that the postsynaptic membrane, although rich in folds at 20 days, is 
flattened out by 60 days of age [89]. Furthermore, other postsynaptic proteins disappear also as the 
AChR density decreases [88]: rapsyn disappears strictly in parallel with the AChR, while utrophin, 
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α-dystrobrevin and also agrin lag behind and can still be efficiently clustered at mutant synapses 
that have already lost most of their AChRs [89]. These data show that ε-containing AChRs are 
required for synaptic localization of rapsyn and maintenance of the postsynaptic apparatus at the 
postnatal NMJ, including postjunctional folds. Together with very recent results showing an active 
role of the AChR in clustering of other postsynaptic proteins (see above), these studies on the ε 
AChR subunit lead to the conclusion that AChRs themselves are actively involved both in 




Formation and maturation of the NMJ occur in several well-defined stages and the nerve and its 
derived factors were previously thought to be the key inducers of the postsynaptic apparatus, in 
particular clusters of the AChR. Although recent progress has revealed a program of muscle pre-
patterning that can lead to aneural AChR clustering, the importance of the nerve, particularly of 
neural agrin remain largely undisputed: without motorneurons, clusters of AChRs are not precisely 
aligned in a narrow band in the center of the muscle, and without agrin (in the presence of the 
nerve), no functional synapses are present at birth. Neural agrin not only redistributes pre-existing 
AChRs but, through its interaction with the neuregulin-1-pathway, also causes new synthesis of 
AChRs. Moreover, agrin stabilizes AChR clusters against their nerve-induced elimination.   
While classic studies on rapsyn-induced clustering of AChRs in heterologous cells led to the 
conclusion that rapsyn is the driving force and is necessary for aggregation of the AChR, recent 
progress has shown that likewise AChRs are required for agrin-induced clustering and synaptic 
localization of rapsyn. In muscle cells in culture, rapsyn and AChRs interact even in the absence of 
neurons or neural agrin. Thus both the AChR and its anchoring protein rapsyn are mutually 
important for aggregation, by forming a pre-assembled protein complex. In cultured myotubes, also 
other postsynaptic proteins, for example MuSK, pre-assemble in complexes independently of neural 
agrin, suggesting that pre-assembly may represent the mechanism of formation of spontaneous 
protein clusters in muscle cells. This nerve-independent pre-assembly is a striking parallel to the 
abiliy of embryonic myofibers to form aneural AChR clusters in the process of muscle pre-
patterning and suggests that formation of pre-assembled protein complexes may also play a role in 
this process.  
Finally, AChRs are also actively involved in agrin-induced clustering of other postsynaptic 
proteins (besides rapsyn) and in maintaining the synaptic accumulation of some proteins, revealing 
that the AChR itself is an active player both in the formation as well as the maintenance of the 
postsynaptic apparatus.  
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Recent studies have also shown that the protein and signaling requirements for formation of 
AChR clusters are different from those for stabilization of such clusters. While components of the 
D/UGC, Src and Fyn are largely dispensable for initial AChR clustering, they are essential, along 
with TrkB, for maintenance of previously induced clusters. It remains to be investigated how the 
signaling mechanisms for formation versus maintenance of AChRs clusters are fine-tuned, in 
particular, what sets of proteins closely interact with the AChR at each step in the formation, 
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Figure 1. The postsynaptic apparatus at the neuromuscular synapse. The scheme depicts 
postsynaptic proteins and their interactions. For simplicity, not all isoforms of NMJ proteins are 
shown and segregation of such proteins between crests and troughs of postjunctional folds is 
neglected. In the case of ErbB-interactions, Shc and SHP2 appear to bind to tyrosine-
phosphorylated ErbB receptors, while the role of tyrosine-phosphorylation for binding to Cdk5 is 
unknown (illustrated by a broken line). p, tyrosine phosphorylation; MuSK, muscle-specific kinase; 
MASC, myotube-associated specificity component; RATL, rapsyn-associated transmembrane 
linker; AChE, acetylcholinesterase.  
 
Figure 2. Schematic structures of agrin (A), MuSK (B) and rapsyn (C). The proteins are not drawn 
to scale. Protein domains are as indicated. In MuSK's cytoplasmic domain, amino acids critical for 
agrin-induced AChR clustering are highlighted by gray circles. GAG, glycosaminoglycan; Ig, 
immunoglobulin. 
 
Figure 3. Model for agrin-induced clustering of postsynaptic proteins in myotubes. Grey arrows 
and bars indicate constitutive steps and protein interactions that occur in the absence of neural agrin. 
Black arrows and bars refer to neural agrin-induced events and protein interactions. In the absence 
of neural agrin, at least two protein complexes exist, an AChR-based complex and a MuSK-based 
complex; the latter may act as a primary synaptic scaffold. Assembly of these complexes may in 
part occur intracellularly within the secretory pathway (post-Golgi vesicle and Golgi apparatus). 
Within the AChR-complex, agrin activates MuSK, which, in a rapsyn-dependent way, causes 
phosphorylation of AChR-bound Src-like kinases and AChR β and δ subunits. Agrin also recruits 
more rapsyn to bind to AChRs before clustering. Within the MuSK complex, following agrin-
induced MuSK activation, Src and Fyn can phosphorylate MuSK and increasingly bind to MuSK. 
Both the AChR- and the MuSK-complex are likely to initiate multiple downstream signaling events 
(indicated by the multiple arrows). Further elements in agrin signaling are Calcium, Rac and Cdc42, 
actin polymerization and NO. Cluster formation occurs at least in part by rapsyn-dependent linkage 
of pre-assembled AChR-rapsyn complexes to the MuSK complex. DG, dystroglycan; p, tyrosine 
phosphorylation.  
 
Figure 4. Cross-talk between the agrin and neuregulin-1 pathways. Agrin appears to be able to 
organize the neuregulin-1 pathway by causing, through MuSK, clustering of neuregulin-1 and 
ErbBs. Neuregulin-1 on the other hand causes increased expression of MuSK. Both pathways lead 
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to activation of JNK. Solid and dashed black arrows indicate direct and indirect signaling steps, 
respectively, and grey arrows with question marks refer to still hypothetical steps. Grey arrows 
(binding, clustering, transcription) indicate general principles of interactions between the agrin and 
neuregulin-1 pathways. Some of these interactions, in particular clustering and transcription, occur 
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